ReviewFrontiers in oncology2021
Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer.
Mridula A George et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
87 papers cite itlatest 60 shown
this paperpooled ittrialcites it